RT Journal Article
SR Electronic
T1 Maximisation of open hospital capacity under shortage of SARS-CoV-2 vaccines
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.08.21253150
DO 10.1101/2021.03.08.21253150
A1 Bosbach, Wolfram A.
A1 Heinrich, Martin
A1 Kolisch, Rainer
A1 Heiss, Christian
YR 2021
UL http://medrxiv.org/content/early/2021/03/12/2021.03.08.21253150.abstract
AB Motive The Covid-19 pandemic has led to the novel situation that hospitals must prioritise staff for a vaccine rollout while there is acute shortage of the vaccine. In spite of the availability of guidelines from state agencies, there is partial confusion about what an optimal rollout plan is. This study investigates effects in a hospital model under different rollout schemes.Methods A simulation model is implemented in VBA and studied for parameter variation. The implemented code is available as open access supplement.Main results A rollout scheme assigning vaccine doses to staff primarily by staff’s pathogen exposure maximises the predicted open hospital capacity when compared to a rollout based on hierarchical prioritisation. The effect increases under resource scarcity and increasing disease activity. Nursing staff benefits most from an exposure focused rollout.Conclusions The model employs SARS-CoV-2 parameters; nonetheless, effects observable in the model are transferable to other infectious diseases. Necessary future prioritisation plans need to consider pathogen characteristics and social factors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Deutsche Forschungsgemeinschaft (DFG) provided mobility funds through grant BO 4961/6-1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB and/or ethics committee approvals required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe model is implemented as Visual Basic for Application (VBA) macro. The macro and its embedded version in Microsoft-Excel are available as open access supplement 1 and 2 under the GNU General Public License version 3, or any later version (doi.org/10.5281/zenodo.4589332). We hope that the open access macro code will further exchange and make accessibility of the study's work easier. https://doi.org/10.5281/zenodo.4589332